Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 11.07M P/E - EPS this Y - Ern Qtrly Grth -
Income -4.35M Forward P/E - EPS next Y - 50D Avg Chg 14.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg 31.00%
Dividend N/A Price/Book 1.57 EPS next 5Y - 52W High Chg -34.00%
Recommedations - Quick Ratio 10.51 Shares Outstanding 88.17M 52W Low Chg 239.00%
Insider Own 18.69% ROA -45.13% Shares Float 71.73M Beta 3.27
Inst Own 0.06% ROE -89.91% Shares Shorted/Prior -/- Price 0.13
Gross Margin - Profit Margin - Avg. Volume 213,419 Target Price -
Oper. Margin - Earnings Date - Volume 284,545 Change 16.51%
About PHARMATHER HOLDINGS LTD

PharmaTher Holdings Ltd., a specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes. The company's product pipeline includes KETARX, a hydrochloride injection for the treatment of Parkinson's disease, Amyotrophic Lateral Sclerosis, complex regional pain and Rett syndrome, and anesthesia and procedural sedation, as well as Ischemia reperfusion injury. It also develops KETARX, a microneedle patch, for mental health, neurological, and pain disorders; and KETARX On-body pump for the maintenance of general anesthesia for diagnostic and surgical procedures. In addition, the company offers PHARMAPATCH, a microneedle patch technology solution, which includes hydrogel-forming and gelatin methacryloyl delivery system for the treatment of psychedelics and infectious diseases. Further, it has license agreement with BioRAE, Inc. for the development and commercialization of a novel biocompatible and biodegradable gelatin methacryloyl microneedle; and the University of Kansas to develop and commercialize the intellectual property of ketamine to treat ALS. The company also holds a patent and know-how license agreement with The Queen's University of Belfast to develop and commercialize hydrogel-forming microneedle patch delivery technology; and a license agreement with Gesval SA, as well as valuation and exclusive option agreement with Case Western Reserve University for development and commercialization for the intellectual property of ketamine for the treatment of Rett syndrome. PharmaTher Holdings Ltd. was incorporated in 2019 and is headquartered in Toronto, Canada.

PHRRF Chatroom

User Image Polecatt613 Posted - 1 day ago

What's this? another sample? Got it out of the po box this 🌅 $MDXXF $PHRRF $MESC.CN $EHVVF.... You guys didn't send out samples like $PHRRF or $OPTHF even $DMTTF send out samplers last summer. 🤣 You're dealing w/ someone who rehydrates their 🥛 🍼 keep the pressure up 💎 ♦️ 🔹️ 💎 ♦️ 🔹️

User Image Polecatt613 Posted - 2 days ago

tbh ill be happy if this 🦃 decides to strut. I'll be staying "put" @ $PHRRF until well after Turkey season ends

User Image Polecatt613 Posted - 2 days ago

$PHRRF almost had me sweating 😅 im thinking 🐇 stays in the 🎩for a few more days. what if it's needed to soften a👊? happy turkey season eve, it runs until May 31st.

User Image Polecatt613 Posted - 3 days ago

$MDXXF $CYBN $EHVVF $PHRRF someone ate my breakfast 🙃 Alright serious about $MESC slick rick & the motley crew better lace up. Fuk I can't even speak the name to Google yet to find out who owns it. I hope you got a plan I ain't jammed

User Image Polecatt613 Posted - 3 days ago

U see everyone of those lowball 000s? I'm eating them all, plus $TPIA if thats a low as she goes... 😆 Buy $PHRRF for real gains & the other jokers for jokes. Should be a nice buy/exit spot today with $PHRM & $MESC don't miss it

User Image Polecatt613 Posted - 5 days ago

$PHRRF took a brush with death this morning before sun up. I'm feeling lucky now, or still in shock more likely. Reminder to change/check your furnace filters extra often this time of the year w/ spring cleaning taking place. Once a month could be one day too long, if you're on propane🙀

User Image Mystockdaily Posted - 5 days ago

$PHRRF receive approval on the GDUFA goal date of April 29, 2024, we are pleased that the FDA review of our ANDA has been completed and no additional deficiencies were mentioned from its original review letter. We have completed the necessary tests and are confirming to ensure our responses accurately reflect the FDA’s comments. We will submit them to address the CRL and obtain a revised GDUFA goal date. I believe that our goal to receive FDA approval for ketamine is closer.” https://finance.yahoo.com/news/pharmather-provides-priority-original-abbreviated-200000620.html

User Image Polecatt613 Posted - 1 week ago

$PHRRF 🇨🇦

User Image Polecatt613 Posted - 1 week ago

$PHRRF

User Image kfactor1469 Posted - 1 week ago

$PHRRF now comes the next hurdle If they can get a new date of approval even projected......will they have enough liquidity to get there

User Image Polecatt613 Posted - 1 week ago

@djamoney @jnranade & I'm chopping a session trying to make my phone type with my voice. U shouldn't drink, u should eat cannabis edibles until you're so high Death feels inevitable 💔 Then when you sober up your happy to be alive, genuinely. U ever woke up after a gin black out & been happy to be alive? What are u drinking ??? I'm selling $PHRRF & $QRDO.X Ketamine FDA approval knocking on the door step w/ Pharmather & Qredo opens at like 6:40 tommrow. How do u not know about this stuff my man?

User Image GEDDER Posted - 1 week ago

$PHRRF $TRKAQ this should be english and means „spam your sis“!!! Keylo needs a dime for the under bridge place….!! 😆👍😆🪳🪳🪳

User Image John_morris Posted - 1 week ago

$PHRRF News of CRL https://finance.yahoo.com/news/pharmather-provides-priority-original-abbreviated-200000620.html

User Image jeremy50641 Posted - 1 week ago

$PHRRF CRL

User Image Polecatt613 Posted - 1 week ago

$PHRRF TD is hiding everything phrm today. They won't even cancel a PHRRF order. Must still be asleep. 0 vol all around it says

User Image Polecatt613 Posted - 1 week ago

$PHRRF late getting back in. Are we all the same today or big news ?

User Image Polecatt613 Posted - 1 week ago

Make it go to the moon today the network opens. I'll be on later, after the market closes. Perfect buy-in time over at $PHRRF today

User Image Polecatt613 Posted - 1 week ago

$PHRRF just pulled a tick off my forehead from Turkey scouting this am... That better be a good luck omen? I already got Doxy on hand 🤣

User Image Polecatt613 Posted - 1 week ago

@SallyFields $PHRRF buy in zone before FDA approval...

User Image Polecatt613 Posted - 1 week ago

$PHRRF still worried about getting burnt here, I guess we just trade until the FDA speaks up. The shortage of Ketamine gives me high hopes, its needed

User Image Polecatt613 Posted - 1 week ago

$PHRRF we have 0.08 - 0.32 on lvl2 CAD Does it run down towards 0.17 CAD reel quick like it ran down today.

User Image Mystockdaily Posted - 1 week ago

$PHRRF Holding strong for the next leg up?

User Image Mystockdaily Posted - 1 week ago

$PHRRF Good to go!

User Image ianchris Posted - 1 week ago

$PHRRF looks like a non-event. Good thing I sold 80% of my stake over 30 cents.

User Image Mystockdaily Posted - 1 week ago

$PHRRF News!! PharmaTher Provides Update of its Priority Original Abbreviated New Drug Application for Ketamine https://finance.yahoo.com/news/pharmather-provides-priority-original-abbreviated-120000352.html

User Image DonCorleone77 Posted - 1 week ago

$PHRRF PharmaTher provides update on priority original ANDA for ketamine PharmaTher Holdings provides an update of its Priority Original Abbreviated New Drug Application for Ketamine that was accepted by the U.S. Food and Drug Administration and assigned a Generic Drug User Fee Amendments of 2022 goal date of April 29, 2024. As announced by the Company on February 12, 2024, the ANDA is under priority review by the FDA and has been provided with preliminary thoughts on possible deficiencies identified by the Quality reviewers. The Company has completed the necessary tests and responses to address the FDA's comments. The Company aims to submit its responses to the FDA by the end of this week. There can be no assurance the GDUFA goal date will be met. Should the goal date not be met, the FDA would provide a Complete Response Letter to the Company to address the responses, provide additional feedback, if any, and assign an appropriate goal date. The Company is prepared to address potential FDA requests and concerns immediately and will update shareholders as they occur. The Company's overall goal is to solve the ketamine shortage problem in the U.S. and its ketamine to adhere to the FDA's strict manufacturing guidelines and FDA-approved prescribing label. Following the anticipated FDA approval and launch in the U.S., the Company aims to pursue international approvals to support the global demand for ketamine. The Company's long-term strategy is pursuing novel uses and delivery methods of ketamine as a potential treatment for pain, mental health, and neurological disorders.

User Image Polecatt613 Posted - 1 week ago

$PHRRF $ENSC $QRDO.X $TURBO.X took a little bit of $BLZ.X today Along w/ 10-20mg of Diazepam each day 🤣 That is what I hold. I trade anything. QREDO's chart doesn't even work anymore, are you voting if you hold?? It opens on the 17th of this month.

User Image Polecatt613 Posted - 1 week ago

$ENSC fook me. Bought more but what a slow day. $250 here & a little in $PHRRF with such low/ slow days. Profit was hard to come-by. Thats like Feb 1 lows again....

User Image Polecatt613 Posted - 1 week ago

$PHRRF you should load.

User Image Polecatt613 Posted - 1 week ago

@TT997 head to $PHRRF to help stop the sideways... maybe it will stretch good today & exercise well when the weather is nice 👌